Literature DB >> 10937066

Protein kinase C (PKC) isoenzymes immunohistochemistry in lymph node revealing solution-fixed, paraffin-embedded bladder tumors.

R Koren1, L Langzam, A Paz, P M Livne, R Gal, S R Sampson.   

Abstract

Protein kinase C (PKC) plays an important role in cellular differentiation and in the malignant process. In an earlier study, it was shown that the expression pattern of PKC isoenzymes is altered in some tumors compared to their corresponding normal tissue. In this study, we evaluated the pattern of PKC isoenzyme immunostaining in bladder transitional cell carcinoma (TCC) of different grades and stages and normal tissue. Twenty-seven TCC samples and six areas of normal bladder mucosa were stained with antibodies specific for the PKC isoenzymes: alpha, beta 1, beta 2, delta, and zeta. The sections were scored for intensity of staining, and the correlation with grade and stage of the tumors was computed. The PKC alpha and beta 2 immunostains were intense in normal urothelium and in all evaluated tumors. PKC beta 1 and delta stains were intense in normal and low-grade and -stage tumors and weak in high-grade and -stage tumors. The opposite trend was found for PKC zeta. PKC isoenzyme expression differs in invasive TCC compared to low-grade, low-stage TCC and normal urothelium. The value of these findings as a marker of tumor aggressiveness should be further assessed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10937066     DOI: 10.1097/00129039-200006000-00013

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  9 in total

1.  Differentiation-Associated Expression of Conventional Protein Kinase C Isoforms in Primary Cultures of Bone Marrow Cells Induced by M-CSF and G-CSF.

Authors:  Xiaohua Li; Hong Meng; Ben D Chen
Journal:  Am J Biomed Sci       Date:  2009-01-01

Review 2.  Protein kinase C: perfectly balanced.

Authors:  Alexandra C Newton
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04       Impact factor: 8.250

3.  Role for protein kinase C delta in the functional activity of human UGT1A6: implications for drug-drug interactions between PKC inhibitors and UGT1A6.

Authors:  L P Volak; M H Court
Journal:  Xenobiotica       Date:  2010-05       Impact factor: 1.908

4.  Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.

Authors:  Corina E Antal; Andrew M Hudson; Emily Kang; Ciro Zanca; Christopher Wirth; Natalie L Stephenson; Eleanor W Trotter; Lisa L Gallegos; Crispin J Miller; Frank B Furnari; Tony Hunter; John Brognard; Alexandra C Newton
Journal:  Cell       Date:  2015-01-22       Impact factor: 41.582

5.  Expression of protein kinase C family in human hepatocellular carcinoma.

Authors:  Hsiu-Chin Lu; Fen-Pi Chou; Kun-Tu Yeh; Ya-Sian Chang; Nicholas C Hsu; Jan-Gowth Chang
Journal:  Pathol Oncol Res       Date:  2009-12-01       Impact factor: 3.201

Review 6.  Reversing the Paradigm: Protein Kinase C as a Tumor Suppressor.

Authors:  Alexandra C Newton; John Brognard
Journal:  Trends Pharmacol Sci       Date:  2017-03-08       Impact factor: 14.819

7.  PKCα phosphorylation of RhoGDI2 at Ser31 disrupts interactions with Rac1 and decreases GDI activity.

Authors:  E M Griner; M E A Churchill; D L Brautigan; D Theodorescu
Journal:  Oncogene       Date:  2012-04-02       Impact factor: 9.867

8.  The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity.

Authors:  Elisabeth Ersvaer; Astrid Olsnes Kittang; Peter Hampson; Kristoffer Sand; Bjørn Tore Gjertsen; Janet M Lord; Oystein Bruserud
Journal:  Toxins (Basel)       Date:  2010-01-22       Impact factor: 4.546

Review 9.  Targeting Protein Kinase C for Cancer Therapy.

Authors:  Sijia He; Qi Li; Qian Huang; Jin Cheng
Journal:  Cancers (Basel)       Date:  2022-02-22       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.